On 4th of March, after the closure of markets, an announcement is expected from Salix Pharmaceuticals Ltd.(NASDAQ:SLXP) that the company…
An Announcement regarding the completion of a range of asset swaps was made concerning two significant companies, GlaxoSmithKline plc (ADR)…
Gilead Sciences Inc. (NASDAQ:GILD) is the single reason why the biotech market is still doing business. At a time when…
Hepatitis C patients will no longer have to undergo treatment for 24 or 48 weeks anymore. Achillion Pharmaceuticals (NASDAQ:ACHN)’s drug…
CVS Health (NYSE:CVS) has had a great fourth quarter of 2014, beating the market expectations and earning the investor’s respect.…
Yesterday Gilead Sciences (NASDAQ:GILD) reported its fourth quarter earnings which exceeded expectations. However, what came as a surprise was the…